Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...
Werewolf’s PREDATOR protein engineering technology creates biological prodrugs that remain inactive in the systemic circulation. These prodrugs are activated into immune stimulants only in the ...